2021 Tri-Con Virtual Poster Presentations
P01: OmicNavigator: Open-Source Software for Omic Data Analysis and Visualization, Presented by Brett E., AbbVie
P02: Salivary Biomarkers and Extracellular Vesicles, Presented by Christa N., Austrian Institute of Technology
P03: System Integration for Point of Care Devices, Presented by Johannes P., Austrian Institute of Technology
P04: High Throughput MSREqPCR for Colon-Cancer DNA-Methylation Biomarker Testing, Presented by Andreas W., Austrian Institute of Technology
P05: Detection of EGFR Mutations in Quantity Insufficient Tissue Slides by High Sensitivity Assay Target Selector in Patients with Non-Small Cell Lung Cancer, Presented by Barbara B., Biocept, Inc.
P06: CellPreserve Apparatus to Extend Rare Cell Lifetime and Provide Methods to Undertake Longitudinal Analysis of Cell Behaviour and Supernatant, Presented by Josh G., Cambridge Consultants
P07: AI-Enabled TB Therapy Improvement for High Burden Countries, Presented by Andrew G., Cambridge Consultants
P08: Flashmob PureSentry: Automated Real-Time Detection of Contamination in Cell and Gene Therapy Manufacture, Presented by Matthew J., Cambridge Consultants
P09: Bypassing Microscopy Limitations Using Computation Imaging, Presented by Alan S., Cambridge Consultants
P10: Scale-Up Challenges for Nanophotonic Biosensors, Presented by Tom W., Cambridge Consultants
P11: Development of a New In Vitro Diagnostic Medical Device for Prediction of Infliximab Treatment Responsiveness to Guide Appropriate Therapy Selection in Rheumatoid Arthritis, Presented by Laszlo S., EGIS Pharmaceuticals PLC
P12: Evaluation of Nucleic Acid Extraction-Free Method for COVID-19 Detection in Saliva Specimen Using Allplex™ SARS-CoV-2 Assay and Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay, Presented by In Bum S., Kangwon National University
P13: Development of a Serum microRNA Panel for Early Lung Cancer Detection, Presented by Tang Yew C., MiRXES
P14: Combination of Blood Biomarkers and Stroke Scales Improves Identification of Large Vessel Occlusions, Presented by Edoardo G., POCKiT diagnostics Ltd.
P15: A Universal Data Model for Longitudinal Integration of Disparate Biomarker and In-Life Patient Data Augmented by Machine Learning, Presented by Rajalaxmi S., PointCross, Inc.
P16: Evaluation of Lyophilized Amplification Reagents for Detection of SARS-CoV-2, Presented by Taylor M., Sandia National Laboratories
P17: Development of an Assay to Detect Multiple Respiratory Viruses, Presented by Niklaus M., Seegene Technologies, Inc.
P18: Large Scale Production, Purification and Partial Characterization of a Recombinant RNAse Inhibitor Produced in Insect Cells, Presented by Gyoergy D., TargetEx Ltd.
P19: Multifunctional Organosilica Nanoparticles for Highly Sensitive Detection and Imaging, Presented by Michihiro N., Yamaguchi University